Vascudyne, Inc.
Clinical trials sponsored by Vascudyne, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Engineered blood vessels could transform heart bypass surgery Results expected Mar 2027 (estimated)
-
Engineered blood vessels could transform heart bypass surgery
Disease control By invitation onlyThis study tests a new lab-made blood vessel (ATEV) for use in coronary artery bypass surgery in 20 people with multi-vessel heart disease. The goal is to see if it is safe and can be successfully implanted as an alternative to using the patient's own veins. Researchers will moni…
Sponsor: Vascudyne, Inc. • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New Lab-Made blood vessel tested in heart bypass patients
Disease control By invitation onlyThis early study tests the safety of a new synthetic tube (Vascudyne CAB A) used to reroute blood around blocked heart arteries. Five adults needing bypass surgery will receive this graft alongside standard grafts. Doctors will check if the graft stays open without problems for u…
Early phase 1 • Sponsor: Vascudyne, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC